AbbVie ABBV
NYSE ABBV
$285.37 +1.97 (+0.70%)
As of: Oct 16, 2026 · 3:59 PM EDT

AbbVie (ABBV) Non-Current Assets (2012 - 2026)

Updated

AbbVie's Non-Current Assets came in at $101.45 billion for Q2 2026, down 6.0% from $107.92 billion a year earlier and down 1.4% from the prior quarter.

Analysis

AbbVie (ABBV) Non-Current Assets (2012 - 2026) Analysis & Trends

At the end of FY2025, AbbVie's Non-Current Assets was $104.9 billion, down 4.3% from FY2024.

  • Non-Current Assets carries a five-year compound annual growth rate of -3.7% (FY2020 to FY2025).
  • Going back by year, Non-Current Assets was $109.58 billion in FY2024 (+7.7%), $101.71 billion in FY2023 (-7.8%), $110.34 billion in FY2022 (-7.0%) and $118.6 billion in FY2021 (-6.2%).
  • The Q2 2026 figure represents the lowest quarterly Non-Current Assets since Q1 2020.
  • Year-over-year, Non-Current Assets has declined for six consecutive quarters, with an average decline of 0.7% over the last eight quarters.
  • The fastest year-over-year change in Non-Current Assets over five years came in Q3 2024 (growth of 12.3%), and the weakest in Q3 2025 (a decline of 8.9%).
  • Business Quant data shows ABBV's Non-Current Assets at $102.93 billion (Q1 2026), $104.9 billion (Q4 2025) and $105.36 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 141.29 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 101.45 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 87.87 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 35.42 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 159.77 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn 14.88 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 101.45 Bn
Mar 31, 2026 102.93 Bn
Dec 31, 2025 104.90 Bn
Sep 30, 2025 105.36 Bn
Jun 30, 2025 107.92 Bn
Mar 31, 2025 108.49 Bn
Dec 31, 2024 109.58 Bn
Sep 30, 2024 115.64 Bn
Jun 30, 2024 108.12 Bn
Mar 31, 2024 110.00 Bn
Dec 31, 2023 101.71 Bn
Sep 30, 2023 103.00 Bn
Jun 30, 2023 106.52 Bn
Mar 31, 2023 108.06 Bn
Dec 31, 2022 110.34 Bn
Sep 30, 2022 110.96 Bn
Jun 30, 2022 114.09 Bn
Mar 31, 2022 116.70 Bn
Dec 31, 2021 118.60 Bn
Sep 30, 2021 119.90 Bn
API Access

AbbVie Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=ABBV&period=max&api_key=YOUR_API_KEY